397 related articles for article (PubMed ID: 29157283)
1. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
Metcalf Pate KA; Blankson JN
Retrovirology; 2017 Nov; 14(1):52. PubMed ID: 29157283
[TBL] [Abstract][Full Text] [Related]
2. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
Charlins P; Schmitt K; Remling-Mulder L; Hogan LE; Hanhauser E; Hobbs KS; Hecht F; Deeks SG; Henrich TJ; Akkina R
Virology; 2017 Jul; 507():135-139. PubMed ID: 28432928
[TBL] [Abstract][Full Text] [Related]
3. The search for a cure for persistent HIV reservoirs.
Lafeuillade A; Stevenson M
AIDS Rev; 2011; 13(2):63-6. PubMed ID: 21587339
[TBL] [Abstract][Full Text] [Related]
4. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
[TBL] [Abstract][Full Text] [Related]
5. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
Siliciano RF
Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
[TBL] [Abstract][Full Text] [Related]
6. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
[TBL] [Abstract][Full Text] [Related]
7. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads.
Metcalf Pate KA; Pohlmeyer CW; Walker-Sperling VE; Foote JB; Najarro KM; Cryer CG; Salgado M; Gama L; Engle EL; Shirk EN; Queen SE; Chioma S; Vermillion MS; Bullock B; Li M; Lyons CE; Adams RJ; Zink MC; Clements JE; Mankowski JL; Blankson JN
J Infect Dis; 2015 Nov; 212(9):1387-96. PubMed ID: 25883388
[TBL] [Abstract][Full Text] [Related]
8. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
9. What can we do to reduce the viral reservoir in HIV-1-infected individuals?
Pohlmeyer CW; Walker-Sperling VE; Blankson JN
Future Microbiol; 2016 Jul; 11():839-42. PubMed ID: 27416850
[No Abstract] [Full Text] [Related]
10. HIV-1 Reservoirs During Suppressive Therapy.
Barton K; Winckelmann A; Palmer S
Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
[TBL] [Abstract][Full Text] [Related]
11. Measuring HIV Persistence on Antiretroviral Therapy.
Horsburgh BA; Palmer S
Adv Exp Med Biol; 2018; 1075():265-284. PubMed ID: 30030797
[TBL] [Abstract][Full Text] [Related]
12. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
[TBL] [Abstract][Full Text] [Related]
13. Latency and reservoirs for HIV-1.
Siliciano RF
AIDS; 1999; 13 Suppl A():S49-58. PubMed ID: 10885762
[No Abstract] [Full Text] [Related]
14. Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda.
Prodger JL; Capoferri AA; Yu K; Lai J; Reynolds SJ; Kasule J; Kityamuweesi T; Buule P; Serwadda D; Kwon KJ; Schlusser K; Martens C; Scully E; Choi YH; Redd AD; Quinn TC
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544096
[TBL] [Abstract][Full Text] [Related]
15. Towards an HIV-1 cure: measuring the latent reservoir.
Bruner KM; Hosmane NN; Siliciano RF
Trends Microbiol; 2015 Apr; 23(4):192-203. PubMed ID: 25747663
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.
Avalos CR; Price SL; Forsyth ER; Pin JN; Shirk EN; Bullock BT; Queen SE; Li M; Gellerup D; O'Connor SL; Zink MC; Mankowski JL; Gama L; Clements JE
J Virol; 2016 Jun; 90(12):5643-5656. PubMed ID: 27030272
[TBL] [Abstract][Full Text] [Related]
17. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
18. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy.
Horiike M; Iwami S; Kodama M; Sato A; Watanabe Y; Yasui M; Ishida Y; Kobayashi T; Miura T; Igarashi T
Virology; 2012 Feb; 423(2):107-18. PubMed ID: 22196013
[TBL] [Abstract][Full Text] [Related]
19. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
Siliciano JD; Siliciano RF
J Infect Dis; 2021 Feb; 223(12 Suppl 2):13-21. PubMed ID: 33586775
[TBL] [Abstract][Full Text] [Related]
20. Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.
Bertagnolli LN; Varriale J; Sweet S; Brockhurst J; Simonetti FR; White J; Beg S; Lynn K; Mounzer K; Frank I; Tebas P; Bar KJ; Montaner LJ; Siliciano RF; Siliciano JD
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32066-32077. PubMed ID: 33239444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
